Annual Retained Earnings
-$1.84 M
-$3.00 M-259.49%
December 31, 2023
Summary
- As of February 21, 2025, BGLC annual retained earnings is -$1.84 million, with the most recent change of -$3.00 million (-259.49%) on December 31, 2023.
- During the last 3 years, BGLC annual retained earnings has fallen by -$2.61 million (-342.42%).
- BGLC annual retained earnings is now -221.95% below its all-time high of $1.51 million, reached on December 31, 2021.
Performance
BGLC Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Retained Earnings
-$3.09 M
-$1.35 M-76.93%
September 30, 2024
Summary
- As of February 21, 2025, BGLC quarterly retained earnings is -$3.09 million, with the most recent change of -$1.35 million (-76.93%) on September 30, 2024.
- Over the past year, BGLC quarterly retained earnings has dropped by -$1.35 million (-76.93%).
- BGLC quarterly retained earnings is now -302.32% below its all-time high of $1.53 million, reached on March 1, 2022.
Performance
BGLC Quarterly Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Retained Earnings Formula
Retained Earnings = Retained Earnings (start of the period) + Net Income − Dividends Paid
BGLC Retained Earnings Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -259.5% | -76.9% |
| 3 y3 years | -342.4% | -384.6% |
| 5 y5 years | -2024.8% | -384.6% |
BGLC Retained Earnings Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -221.9% | at low | -302.3% | at low |
| 5 y | 5-year | -221.9% | at low | -302.3% | at low |
| alltime | all time | -221.9% | at low | -302.3% | at low |
BioNexus Gene Lab Retained Earnings History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -$3.09 M(+76.9%) |
| Jun 2024 | - | -$1.75 M(-10.2%) |
| Mar 2024 | - | -$1.95 M(+5.6%) |
| Dec 2023 | -$1.84 M(-259.5%) | -$1.84 M(+3.6%) |
| Sep 2023 | - | -$1.78 M(-315.0%) |
| Jun 2023 | - | $828.10 K(-23.8%) |
| Mar 2023 | - | $1.09 M(-6.0%) |
| Dec 2022 | $1.16 M(-23.5%) | $1.16 M(-12.0%) |
| Sep 2022 | - | $1.31 M(-5.6%) |
| Jun 2022 | - | $1.39 M(-9.1%) |
| Mar 2022 | - | $1.53 M |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2021 | $1.51 M(+98.8%) | - |
| Dec 2021 | - | $1.51 M(+6.3%) |
| Sep 2021 | - | $1.42 M(+26.2%) |
| Jun 2021 | - | $1.13 M(+2.6%) |
| Mar 2021 | - | $1.10 M(+44.5%) |
| Dec 2020 | $760.80 K(-328.3%) | $760.80 K(-249.8%) |
| Sep 2020 | - | -$507.80 K(+13.4%) |
| Jun 2020 | - | -$447.80 K(+17.4%) |
| Mar 2020 | - | -$381.30 K(+14.4%) |
| Dec 2019 | -$333.30 K(+284.0%) | -$333.30 K |
| Dec 2018 | -$86.80 K | - |
FAQ
- What is BioNexus Gene Lab annual retained earnings?
- What is the all time high annual retained earnings for BioNexus Gene Lab?
- What is BioNexus Gene Lab annual retained earnings year-on-year change?
- What is BioNexus Gene Lab quarterly retained earnings?
- What is the all time high quarterly retained earnings for BioNexus Gene Lab?
- What is BioNexus Gene Lab quarterly retained earnings year-on-year change?
What is BioNexus Gene Lab annual retained earnings?
The current annual retained earnings of BGLC is -$1.84 M
What is the all time high annual retained earnings for BioNexus Gene Lab?
BioNexus Gene Lab all-time high annual retained earnings is $1.51 M
What is BioNexus Gene Lab annual retained earnings year-on-year change?
Over the past year, BGLC annual retained earnings has changed by -$3.00 M (-259.49%)
What is BioNexus Gene Lab quarterly retained earnings?
The current quarterly retained earnings of BGLC is -$3.09 M
What is the all time high quarterly retained earnings for BioNexus Gene Lab?
BioNexus Gene Lab all-time high quarterly retained earnings is $1.53 M
What is BioNexus Gene Lab quarterly retained earnings year-on-year change?
Over the past year, BGLC quarterly retained earnings has changed by -$1.35 M (-76.93%)